Combination of dual-targeted therapies and chemotherapy shows high response rates in BRAF-mutated metastatic colorectal cancer: Clinical trial finds 60.9% overall response rate (ORR) with combination of encorafenib, cetuximab and mFOLFOX6 compared to 40% with standard-of-care (SOC) treatment.

1 month ago 41
submitted by /u/FunnyGamer97
[link] [comments]
Read Entire Article
  1. Homepage
  2. Science
  3. Combination of dual-targeted therapies and chemotherapy shows high response rates in BRAF-mutated metastatic colorectal cancer: Clinical trial finds 60.9% overall response rate (ORR) with combination of encorafenib, cetuximab and mFOLFOX6 compared to 40% with standard-of-care (SOC) treatment.

Related

First study to pinpoint a single brain area capable of halting aggressive social behavior and encouraging pro-social actions. Reducing the activity of this brain area lessened aggressive behaviors in mice and encouraged more sociable interactions.

First study to pinpoint a single brain area capable of halti...

2 hours ago 2
Stepped labyrinth seals with optimized geometry reduce lubricant loss in space applications, and simulations closely match experimental data, improving reliability over traditional analytical models

Stepped labyrinth seals with optimized geometry reduce lubri...

4 hours ago 6
People in virtual reality evacuated buildings in a similar way to real life, making similar decisions and looking at the same signs, but they moved more slowly because of the way they had to control their movement.

People in virtual reality evacuated buildings in a similar w...

4 hours ago 5

Hidden in mobile, Best for skyscrapers.